Late-Stage Intermolecular CH Activation for Lead Diversification: A Highly Chemoselective Oxyfunctionalization of the C-9 Position of Potent Bryostatin Analogues
Paul A. Wender(Stanford University), A. Mayweg(Roche (Switzerland)), Michael K. Hilinski(Stanford University)
Cited by 97
Related Papers
Structure-Based Design and Synthesis of Potent Cyclic Peptides Inhibiting the YAP–TEAD Protein–Protein Interaction
|ACS Medicinal Chemistry Letters|2014|174
Circular RNA vaccine induces potent T cell responses
|Proceedings of the National Academy of Sciences|2023|148
β-Secretase (BACE1) Inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer’s Disease
|Journal of Medicinal Chemistry|2013|138
Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid Inhibitors
|Journal of Medicinal Chemistry|2016|75
Discovery of RG7834: The First-in-Class Selective and Orally Available Small Molecule Hepatitis B Virus Expression Inhibitor with Novel Mechanism of Action
|Journal of Medicinal Chemistry|2018|75